Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro

World Journal of Gastroenterology

Volumn 14, Issue 10, 2008, Pages 1592-1597

  He, Yong Wen ^a   Guo, Chun Xia ^a   Pan, Yan Feng ^b   Peng, Cheng ^a   Weng, Zhi Hong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Antiviral agent; Hepatitis B virus; Pokeweed antiviral protein

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; POKEWEED ANTIVIRUS PROTEIN; RNA; VIRUS DNA;

ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN HEPG2; CYTOTOXICITY; DNA TRANSFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; VIRUS REPLICATION;

EID: 41549094106     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.1592     Document Type: Article

References (30)

1. Kurinov IV, Uckun FM. High resolution X-ray structure of potent anti-HIV pokeweed antiviral protein-III. Biochem Pharmacol 2003; 65: 1709-1717
2. Rajamohan F, Ozer Z, Mao C, Uckun FM. Active center cleft residues of pokeweed antiviral protein mediate its high-affinity binding to the ribosomal protein L3. Biochemistry 2001; 40: 9104-9114
3. Parikh BA, Tumer NE. Antiviral activity of ribosome inactivating proteins in medicine. Mini Rev Med Chem 2004; 4: 523-543
4. D'Cruz OJ, Waurzyniakt B, Uckun FM. A 13-week subchronic intravaginal toxicity study of pokeweed antiviral protein in mice. Phytomedicine 2004; 11: 342-351
5. Van Oijen MG, Preijers FW. Rationale for the use of immunotoxins in the treatment of HIV-infected humans. J Drug Target 1998; 5: 75-91
6. Ganem D, Prince AM. Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 2004; 350: 1118-1129
7. The EASL Jury. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version). J Hepatol 2003; 38: 533-540
8. Gish RG, Perrillo RP, Jacobson IM. Customizing the management of chronic hepatitis B virus infection. Semin Liver Dis 2007; 27 Suppl 1: 9-17
9. Lu X, Hazboun T, Block T. Limited proteolysis induces woodchuck hepatitis virus infectivity for human HepG2 cells. Virus Res 2001; 73: 27-40
10. Rajamohan F, Engstrom CR, Denton TJ, Engen LA, Kourinov I, Uckun FM. High-level expression and purification of biologically active recombinant pokeweed antiviral protein. Protein Expr Purif 1999; 16: 359-368
11. Rajamohan F, Kurinov IV, Venkatachalam TK, Uckun FM. Deguanylation of human immunodeficiency virus (HIV-1) RNA by recombinant pokeweed antiviral protein. Biochem Biophys Res Commun 1999; 263: 419-424
12. Hudak KA, Bauman JD, Tumer NE. Pokeweed antiviral protein binds to the cap structure of eukaryotic mRNA and depurinates the mRNA downstream of the cap. RNA 2002; 8: 1148-1159
13. Mansouri S, Nourollahzadeh E, Hudak KA. Pokeweed antiviral protein depurinates the sarcin/ricin loop of the rRNA prior to binding of aminoacyl-tRNA to the ribosomal A-site. RNA 2006; 12: 1683-1692
14. Qi L, Nett TM, Allen MC, Sha X, Harrison CS, Frederick BA, Crawford ED, Glode LM. Binding and cytotoxicity of conjugated and recombinant fusion proteins targeted to the gonadotropin-releasing hormone receptor. Cancer Res 2004; 64: 2090-2095
15. Ball BA, Sabeur K, Nett T, Liu IK. Effects of a GnRH cytotoxin on reproductive function in peripubertal male dogs. Theriogenology 2006; 66: 766-774
16. Honjo E, Watanabe K. Expression of mature pokeweed antiviral protein with or without C-terminal extrapeptide in Escherichia coli as a fusion with maltose-binding protein. Biosci Biotechnol Biochem 1999; 63: 1291-1294
17. D'Cruz OJ, Uckun FM. Pokeweed antiviral protein: a potential nonspermicidal prophylactic antiviral agent. Fertil Steril 2001; 75: 106-114
18. Roday S, Saen-oon S, Schramm VL. Vinyldeoxyadenosine in a sarcin-ricin RNA loop and its binding to ricin toxin a-chain. Biochemistry 2007; 46: 6169-6182
19. Katayama DS, Cornell Manning M, Jarosz P. Solution behavior of a novel biopharmaceutical drug candidate: a gonadotropin-toxin conjugate. Drug Dev Ind Pharm 2006; 32: 1175-1184
20. Parikh BA, Baykal U, Di R, Tumer NE. Evidence for retrotranslocation of pokeweed antiviral protein from endoplasmic reticulum into cytosol and separation of its activity on ribosomes from its activity on capped RNA. Biochemistry 2005; 44: 2478-2490
21. Baykal U, Tumer NE. The C-terminus of pokeweed antiviral protein has distinct roles in transport to the cytosol, ribosome depurination and cytotoxicity. Plant J 2007; 49: 995-1007
22. Picard D, Kao CC, Hudak KA. Pokeweed antiviral protein inhibits brome mosaic virus replication in plant cells. J Biol Chem 2005; 280: 20069-20075
23. Uckun FM, Rustamova L, Vassilev AO, Tibbles HE, Petkevich AS. CNS activity of Pokeweed anti-viral protein (PAP) in mice infected with lymphocytic choriomeningitis virus (LCMV). BMC Infect Dis 2005; 5: 9
24. Rajamohan F, Venkatachalam TK, Irvin JD, Uckun FM. Pokeweed antiviral protein isoforms PAP-I, PAP-II, and PAP-III depurinate RNA of human immunodeficiency virus (HIV)-1. Biochem Biophys Res Commun 1999; 260: 453-458
25. Aceto S, Di Maro A, Conforto B, Siniscalco GG, Parente A, Delli Bovi P, Gaudio L. Nicking activity on pBR322 DNA of ribosome inactivating proteins from Phytolacca dioica L. leaves. Biol Chem 2005; 386: 307-317
26. Wang M, Hudak KA. A novel interaction of pokeweed antiviral protein with translation initiation factors 4G and iso4G: a potential indirect mechanism to access viral RNAs. Nucleic Acids Res 2006; 34: 1174-1181
27. Iyer RP, Jin Y, Roland A, Morrey JD, Mounir S, Korba B. Phosphorothioate di- and trinucleotides as a novel class of anti-hepatitis B virus agents. Antimicrob Agents Chemother 2004; 48: 2199-2205
28. Brunelle MN, Jacquard AC, Pichoud C, Durantel D, Carrouee-Durantel S, Villeneuve JP, Trepo C, Zoulim F. Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir. Hepatology 2005; 41: 1391-1398
29. Uckun FM, Rajamohan F, Pendergrass S, Ozer Z, Waurzyniak B, Mao C. Structure-based design and engineering of a nontoxic recombinant pokeweed antiviral protein with potent anti-human immunodeficiency virus activity. Antimicrob Agents Chemother 2003; 47: 1052-1061
30. D'Cruz OJ, Waurzyniak B, Uckun FM. Mucosal toxicity studies of a gel formulation of native pokeweed antiviral protein. Toxicol Pathol 2004; 32: 212-221